Home > Qtrly Results > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Quarterly Results Analysis [Dec2023]

COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Quarterly Results

Consolidated Dec2023
UnAudited
Sep2023
Audited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Sep2022
Audited
Jun2022
UnAudited
Mar2022
Audited
Revenues ₹2,507 Cr ₹3,207 Cr ₹3,402 Cr ₹3,374 Cr ₹3,100 Cr ₹3,018 Cr ₹2,777 Cr ₹3,019 Cr
Expenses ₹2,715 Cr ₹2,745 Cr ₹2,770 Cr ₹2,769 Cr ₹2,626 Cr ₹2,539 Cr ₹2,346 Cr ₹2,556 Cr
Operating Income ₹-209 Cr ₹462 Cr ₹631 Cr ₹605 Cr ₹474 Cr ₹479 Cr ₹432 Cr ₹463 Cr
Other Income ₹45 Cr ₹2 Cr ₹21 Cr ₹-40 Cr ₹71 Cr ₹86 Cr ₹183 Cr ₹107 Cr
Interest ₹134 Cr ₹121 Cr ₹112 Cr ₹109 Cr ₹97 Cr ₹83 Cr ₹60 Cr ₹87 Cr
Depreciation ₹147 Cr ₹141 Cr ₹155 Cr ₹147 Cr ₹152 Cr ₹146 Cr ₹147 Cr ₹132 Cr
Profit Before Tax ₹-521 Cr ₹-124 Cr ₹333 Cr ₹-491 Cr ₹330 Cr ₹337 Cr ₹408 Cr ₹270 Cr
Profit After Tax ₹-450 Cr ₹-180 Cr ₹173 Cr ₹-403 Cr ₹186 Cr ₹172 Cr ₹211 Cr ₹173 Cr
EPS ₹-12.45 ₹-2.90 ₹5.31 ₹-15.18 ₹9.66 ₹9.23 ₹6.82 ₹5.51
Industry Peers & Returns1W1M1Y
GLENMARK PHARMACEUTICALS 4% 6.2% 118%
SUN PHARMACEUTICAL INDUSTRIES 3% 2.3% 68.2%
CIPLA 2.5% 0.4% 71.7%
DR REDDYS LABORATORIES -0.2% -4.9% 40.3%
ZYDUS LIFESCIENCES 5% 10.4% 109.1%
DIVIS LABORATORIES -1.6% -7% 23.8%
MANKIND PHARMA NA NA NA
TORRENT PHARMACEUTICALS 2.9% -2.2% 69%
LUPIN 2.8% 0% 147.8%

GLENMARK PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

-21.85 %

Y-o-Y

-19.14 %

Quarters Revenues % Change
Dec2023 ₹2,507 Cr
-21.85
Sep2023 ₹3,207 Cr
-5.71
Jun2023 ₹3,402 Cr
0.83
Mar2023 ₹3,374 Cr
8.82
Dec2022 ₹3,100 Cr
2.73
Sep2022 ₹3,018 Cr
8.66
Jun2022 ₹2,777 Cr
-8.01
Mar2022 ₹3,019 Cr -

GLENMARK PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

Negative

Y-o-Y

Negative

Quarters Operating Profit % Change
Dec2023 ₹-209 Cr
Negative
Sep2023 ₹462 Cr
-26.76
Jun2023 ₹631 Cr
4.34
Mar2023 ₹605 Cr
27.62
Dec2022 ₹474 Cr
-1.03
Sep2022 ₹479 Cr
10.98
Jun2022 ₹432 Cr
-6.86
Mar2022 ₹463 Cr -
Operating Margins
Q-o-Q

Negative

Y-o-Y

Negative

Quarters Operating Margin% % Change
Dec2023 -8.32%
Negative
Sep2023 14.41%
-22.36
Jun2023 18.56%
3.51
Mar2023 17.93%
17.27
Dec2022 15.29%
-3.65
Sep2022 15.87%
2.12
Jun2022 15.54%
1.24
Mar2022 15.35% -

GLENMARK PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

Negative

Y-o-Y

Negative

Quarters Profit After Tax % Change
Dec2023 ₹-450 Cr
Negative
Sep2023 ₹-180 Cr
Negative
Jun2023 ₹173 Cr
Positive
Mar2023 ₹-403 Cr
Negative
Dec2022 ₹186 Cr
8.14
Sep2022 ₹172 Cr
-18.62
Jun2022 ₹211 Cr
22.33
Mar2022 ₹173 Cr -
PAT Margins
Q-o-Q

Negative

Y-o-Y

Negative

Quarters PAT Margin(%) % Change
Dec2023 -17.94 %
Negative
Sep2023 -5.62 %
Negative
Jun2023 5.09 %
Positive
Mar2023 -11.95 %
Negative
Dec2022 5.99 %
5.27
Sep2022 5.69 %
-25.13
Jun2022 7.6 %
32.87
Mar2022 5.72 % -

GLENMARK PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

Negative

Y-o-Y

Negative

Quarters EPS % Change
Dec2023 ₹-12.45
Negative
Sep2023 ₹-2.9
Negative
Jun2023 ₹5.31
Positive
Mar2023 ₹-15.18
Negative
Dec2022 ₹9.66
4.66
Sep2022 ₹9.23
35.34
Jun2022 ₹6.82
23.77
Mar2022 ₹5.51 -

You may also like the below Video Courses